The modulatory effect and implication of gut microbiota to osteoporosis: from the perspective of "brain-gut-bone" axis

2021 ◽  
Author(s):  
Yuan-Wei Zhang ◽  
Ying-Juan Li ◽  
Pan-Pan Lu ◽  
Guang-Chun Dai ◽  
Xiang-Xu Chen ◽  
...  

Osteoporosis (OP) is a kind of systemic metabolic disease characterized by the decreased bone mass and destruction of bone microstructure. In recent years, it has become an expectant research trend...

2021 ◽  
Vol 69 (37) ◽  
pp. 10907-10919
Author(s):  
Hao Suo ◽  
Mohammad Rezaul Islam Shishir ◽  
Jianbo Xiao ◽  
Mingfu Wang ◽  
Feng Chen ◽  
...  

2019 ◽  
Vol 3 (Supplement_1) ◽  
Author(s):  
Ji-Hee Shin ◽  
Sunhee Jung ◽  
Min-Sook Kang ◽  
Geum-Sook Hwang ◽  
Dong-Mi Shin

Abstract Objectives Habitual diet influences the intestinal microbiota and metabolites profiles, thereby influencing host physiology. In particular, the westernized diet can contribute to the pathogenesis of metabolic disease whereas, traditional Korean (TK) diet which is rich in plant-based products and low in animal fat and protein provides health benefits. However, both from the gut microbial and metabolic point of view, the exact comparing westernized diet and the TK diet in regard to the biological mechanisms of metabolic disease development have not been studied yet. Therefore, the aim of this study was to compare the effect of the TK diet and the western diet on metabolites and gut microbiota profiling in obese and/or overweight volunteers. Methods A randomized crossover clinical trial was conducted. Sixty-one subjects were randomly allocated to one of six possible sequential orders for consuming the three diets (traditional Korean (TK) diet, traditional American (TA) diet, recommended American (RA) diet). Each of the three intervention phases was 4 weeks in duration separated by a 2-week. Using 16S rRNA-targeted sequencing as well as serum and urinary metabolomic platforms, we compared gut microbiota and metabolites composition at the time point before and after each diet intervention. Results The diversity of gut microbiota was increased by TK diet intervention but not in TA and RA diet intervention. The TK diet consumption subjects had a reduced abundance of rx4–4, Parabacteroides, and Lactococcus, while an increased abundance of Pyramidobacter, Neisseria, Lachnospira, and Blautia compared with TA diet. The relative abundance of Bifidobacterium was negatively correlated with serum branched-chain amino acid (BCAA) only after TK diet intervention. Also, gut microbial lipid metabolism was positively correlated with serum trimethylamine N-oxide (TMAO), betaine, and choline only after TK diet intervention. Conclusions Our observations provide evidence that alteration of metabolites and gut microbiota profiles by dietary patterns would influence host metabolic status, which has relevance for metabolic disease. Funding Sources This study was supported by ‘Research Program for Agricultural Science and Technology Development’, National Academy of Agricultural Science, Rural Development Administration, Republic of Korea (Project No. PJ013475032019).


2020 ◽  
Vol 79 (OCE2) ◽  
Author(s):  
Giulia Gaudioso ◽  
Debora Collotta ◽  
Fausto Chiazza ◽  
Raffaella Mastrocola ◽  
Alessia Cento ◽  
...  

AbstractIntroduction:High sugar consumption promotes endogenous formation of advanced glycation end-products (AGEs), a heterogeneous class of molecules originated from non-enzymatic glycation between reducing sugars and free amino groups of proteins, nucleic acids, or lipids. AGEs accumulation in tissues has been linked to aging and diabetes complications. AGEs might also play an independent role in inflammation and development of cardiovascular disease (CVD). Exogenous dietary AGEs, due to excess intake of modern heat-treated foods, might act synergistically with endogenous AGEs, thus contributing to increase inflammation and CVD. A large amount of ingested AGEs reaches the colon, where they might affect gut microbial metabolism, for example, by acting as substrate for colonic bacterial fermentation, driving alterations of microbiota composition and of intestinal permeability. However in vitro and in vivo studies (animal and human) on the impact of AGEs on the gut microbiota are discordant. This study on mice aims to link the modulation of gut microbiota by AGEs-enriched diet (AGE-D) with metabolic and inflammatory markers.Materials and methods:C57BL/6 mice were randomly allocated into the following dietary regimens: Control (n = 24) and AGE-D (n = 20) for 22 weeks. AGE-D was prepared replacing casein (200 g/kg diet) by an equal amount of modified casein where 10% of arginine was glycated with MG-H1 (methylglyoxal 5-hydro-5-methylimidazolone) for a total of 4 μmol of MG-H1 per g of diet. Faeces were collected using metabolic cages (18 h starving) at week 0, 11 and 22 for fecal DNA extraction and 16SrRNA analysis through Illumina MiSeq using V3-V4 targeted primers. After 22 weeks of dietary manipulation, mice were sacrificed, plasma and organ lipid profiles and serum metabolic and inflammatory profiles were determined.Results and discussion:AGE-D caused a significant reduction in the blood levels of two important components of the incretin system, GIP and GLP-1, when compared to control diet, suggestive of unbalance in the incretin-insulin axis. AGE-D exposure was associated with a significant increase in systemic concentrations of inflammatory cytokines, e.g. IL-1β and IL-17, and PAI-1, which has been suggested as both reliable marker and critical mediator of cellular senescence. We will present how AGEs impact on microbiome community structure and correlate changes in gut microbiota with GIP and GLP-1 levels.Conclusions:AGEs, characteristic of modern processed foods, appear to impact on the incretin-insulin axis, a key regulator of metabolic disease risk. Diets rich in AGEs may mediate these physiological effects at least in part, by reshaping intestinal microbiota structure.


2017 ◽  
Vol 34 ◽  
pp. 3-9 ◽  
Author(s):  
Amy C. Reynolds ◽  
Jessica L. Paterson ◽  
Sally A. Ferguson ◽  
Dragana Stanley ◽  
Kenneth P. Wright ◽  
...  

2012 ◽  
Vol 27 (6) ◽  
pp. 1357-1367 ◽  
Author(s):  
Klara Sjögren ◽  
Cecilia Engdahl ◽  
Petra Henning ◽  
Ulf H Lerner ◽  
Valentina Tremaroli ◽  
...  
Keyword(s):  

2016 ◽  
Vol 113 (47) ◽  
pp. E7554-E7563 ◽  
Author(s):  
Jing Yan ◽  
Jeremy W. Herzog ◽  
Kelly Tsang ◽  
Caitlin A. Brennan ◽  
Maureen A. Bower ◽  
...  

Appreciation of the role of the gut microbiome in regulating vertebrate metabolism has exploded recently. However, the effects of gut microbiota on skeletal growth and homeostasis have only recently begun to be explored. Here, we report that colonization of sexually mature germ-free (GF) mice with conventional specific pathogen-free (SPF) gut microbiota increases both bone formation and resorption, with the net effect of colonization varying with the duration of colonization. Although colonization of adult mice acutely reduces bone mass, in long-term colonized mice, an increase in bone formation and growth plate activity predominates, resulting in equalization of bone mass and increased longitudinal and radial bone growth. Serum levels of insulin-like growth factor 1 (IGF-1), a hormone with known actions on skeletal growth, are substantially increased in response to microbial colonization, with significant increases in liver and adipose tissue IGF-1 production. Antibiotic treatment of conventional mice, in contrast, decreases serum IGF-1 and inhibits bone formation. Supplementation of antibiotic-treated mice with short-chain fatty acids (SCFAs), products of microbial metabolism, restores IGF-1 and bone mass to levels seen in nonantibiotic-treated mice. Thus, SCFA production may be one mechanism by which microbiota increase serum IGF-1. Our study demonstrates that gut microbiota provide a net anabolic stimulus to the skeleton, which is likely mediated by IGF-1. Manipulation of the microbiome or its metabolites may afford opportunities to optimize bone health and growth.


2014 ◽  
Vol 73 (2) ◽  
pp. 172-185 ◽  
Author(s):  
Kieran M. Tuohy ◽  
Francesca Fava ◽  
Roberto Viola

The human gut microbiota has been identified as a possible novel CVD risk factor. This review aims to summarise recent insights connecting human gut microbiome activities with CVD and how such activities may be modulated by diet. Aberrant gut microbiota profiles have been associated with obesity, type 1 and type 2 diabetes and non-alcoholic fatty liver disease. Transfer of microbiota from obese animals induces metabolic disease and obesity in germ-free animals. Conversely, transfer of pathogen-free microbiota from lean healthy human donors to patients with metabolic disease can increase insulin sensitivity. Not only are aberrant microbiota profiles associated with metabolic disease, but the flux of metabolites derived from gut microbial metabolism of choline, phosphatidylcholine andl-carnitine has been shown to contribute directly to CVD pathology, providing one explanation for increased disease risk of eating too much red meat. Diet, especially high intake of fermentable fibres and plant polyphenols, appears to regulate microbial activities within the gut, supporting regulatory guidelines encouraging increased consumption of whole-plant foods (fruit, vegetables and whole-grain cereals), and providing the scientific rationale for the design of efficacious prebiotics. Similarly, recent human studies with carefully selected probiotic strains show that ingestion of viable microorganisms with the ability to hydrolyse bile salts can lower blood cholesterol, a recognised risk factor in CVD. Taken together such observations raise the intriguing possibility that gut microbiome modulation by whole-plant foods, probiotics and prebiotics may be at the base of healthy eating pyramids advised by regulatory agencies across the globe. In conclusion, dietary strategies which modulate the gut microbiota or their metabolic activities are emerging as efficacious tools for reducing CVD risk and indicate that indeed, the way to a healthy heart may be through a healthy gut microbiota.


2015 ◽  
Vol 22 (1) ◽  
pp. 100-112 ◽  
Author(s):  
Lucile Garidou ◽  
Céline Pomié ◽  
Pascale Klopp ◽  
Aurélie Waget ◽  
Julie Charpentier ◽  
...  

Aging ◽  
2020 ◽  
Vol 12 (11) ◽  
pp. 10736-10753 ◽  
Author(s):  
Sicong Ma ◽  
Jinhong Qin ◽  
Yongqiang Hao ◽  
Ying Shi ◽  
Lingjie Fu

Sign in / Sign up

Export Citation Format

Share Document